Lataa...

Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease

BACKGROUND: Objective monitoring of the severity of inflammation in patients with inflammatory bowel disease (IBD) is an essential part of disease management. However, repeat endoscopy to define extent and severity of inflammation is not practical. Fecal calprotectin (FC) is a biomarker that can be...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Can J Gastroenterol Hepatol
Päätekijät: Bressler, Brian, Panaccione, Remo, Fedorak, Richard N, Seidman, Ernest G
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Pulsus Group Inc 2015
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4610647/
https://ncbi.nlm.nih.gov/pubmed/26125109
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!